We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$28.8B
AUM Growth
-$783M
Cap. Flow
-$2.41B
Cap. Flow %
-8.37%
Top 10 Hldgs %
9.51%
Holding
1,466
New
69
Increased
389
Reduced
586
Closed
155

Top Buys

Rank Stock Value
1
AXE
Anixter International Inc
AXE
+$64.8M
2
APAM icon
Artisan Partners
APAM
+$56.9M
3
DORM icon
Dorman Products
DORM
+$52.1M
4
RES icon
RPC Inc
RES
+$46.1M
5
NUS icon
Nu Skin
NUS
+$42.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.03%
2 Technology 18.79%
3 Consumer Discretionary 15.93%
4 Financials 10.69%
5 Materials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUX icon
926
McEwen Inc
MUX
$1.14B
$2.6M 0.01%
234,200
-379,183
-62% -$5.31M
MX icon
927
Magnachip Semiconductor
MX
$102M
$2.6M 0.01%
200,040
-27,900
-12% -$327K
PTCT icon
928
PTC Therapeutics
PTCT
$5.48B
$2.59M 0.01%
50,000
NEWT icon
929
NewtekOne
NEWT
$349M
$2.58M 0.01%
+174,500
New +$2.39M
CGRN
930
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$2.58M 0.01%
17,425
-6,000
-26% -$1.04M
AIZ icon
931
Assurant
AIZ
$14.1B
$2.57M 0.01%
37,512
+2,300
+7% +$153K
LAND
932
Gladstone Land Corp
LAND
$406M
$2.56M 0.01%
239,500
-261,700
-52% -$2.84M
LXRX icon
933
Lexicon Pharmaceuticals
LXRX
$894M
$2.56M 0.01%
401,976
+11,100
+3% +$89.5K
DYAX
934
DELISTED
DYAX CORPORATION
DYAX
$2.52M 0.01%
179,600
-65,300
-27% -$817K
RPRX
935
DELISTED
Repros Therapeutics Inc.
RPRX
$2.5M 0.01%
+251,000
New +$2.14M
AMTD
936
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.5M 0.01%
69,900
DOX icon
937
Amdocs
DOX
$6.51B
$2.5M 0.01%
53,500
+1,500
+3% +$70.3K
PKD
938
DELISTED
Parker Drilling Company
PKD
$2.48M 0.01%
53,767
-43,266
-45% -$2.52M
UTMD icon
939
Utah Medical Products
UTMD
$238M
$2.41M 0.01%
40,100
-4,200
-9% -$233K
FOR icon
940
Forestar Group
FOR
$1.37B
$2.39M 0.01%
155,000
EG icon
941
Everest Group
EG
$14.6B
$2.37M 0.01%
13,900
+100
+0.7% +$16.9K
GTT
942
DELISTED
GTT Communications, Inc.
GTT
$2.35M 0.01%
177,960
-54,700
-24% -$701K
HIL
943
DELISTED
Hill International, Inc. Common Stock
HIL
$2.35M 0.01%
611,107
-63,000
-9% -$231K
TSS
944
DELISTED
Total System Services, Inc.
TSS
$2.34M 0.01%
68,895
-22,100
-24% -$715K
EJ
945
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$2.33M 0.01%
322,400
-1,332,919
-81% -$11.4M
ROC
946
DELISTED
ROCKWOOD HLDGS INC
ROC
$2.32M 0.01%
29,400
-29,000
-50% -$2.24M
GFIG
947
DELISTED
GFI GROUP INC
GFIG
$2.31M 0.01%
424,000
-40,000
-9% -$210K
BAS
948
DELISTED
Basis Energy Services, Inc.
BAS
$2.24M 0.01%
561
-159
-22% -$1M
PLCM
949
DELISTED
POLYCOM INC
PLCM
$2.23M 0.01%
165,000
INOD icon
950
Innodata
INOD
$1.87B
$2.19M 0.01%
751,589
+54,989
+8% +$154K

Similar funds

Royce & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Royce & Associates held 1,466 positions worth $28.8B, down 2.6% from $29.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $2.41B in Q4 2014, closing 155 positions and reducing 586 holdings. Its most notable exit was Strategic Education, an estimated $42.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Avid Technology Inc worth $27.2M.

  • Royce & Associates's largest Q4 2014 buy was Avid Technology Inc: 1,911,784 shares worth $27.2M.
  • Royce & Associates added most to Anixter International Inc in Q4 2014, an estimated $64.8M increase.
  • Royce & Associates's biggest Q4 2014 reduction was Myriad Genetics, cutting an estimated $136M.
  • Royce & Associates fully exited Strategic Education in Q4 2014, selling an estimated $42.5M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $28.8B portfolio in Q4 2014.
  • Royce & Associates opened 69 new positions and closed 155 in Q4 2014.
  • Royce & Associates's portfolio value fell 2.6% quarter-over-quarter to $28.8B.

Based on Royce & Associates's 13F filing for Q4 2014, filed 9 Feb 2015.